Given that Arf6 deletion prevented primary tumor acceleration caused by PTEN loss (Fig. 3f–g), there is a component of ARF6-dependent survival that is necessary for, and/or functions independently of the PI3K pathway. The gene discussed is ARF6; the disease is neoplasm.